Case Report: Treatment with Pien-Tze-Huang for Prolonged Positive SARS-CoV-2 Test Results in COVID-19 Patients: A Report of Five Cases

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Aug 26

PMID 36017009

Authors

Yujiao Zheng

Jinbo Cheng

Chengjuan Gu

Mingzhong Xiao

Zuoyu Shao

Linhua Zhao

Xiaolin Tong

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) has rapidly spread around the world since December 2019, becoming a global pandemic. Atypical cases of COVID-19, manifesting as prolonged positive SARS-CoV-2 test results during the convalescence period, have been encountered. These cases increase the difficulty of COVID-19 prevention and treatment. Here, we report five cases of COVID-19 patients who demonstrated prolonged positive SARS-CoV-2 tests after regular traditional Chinese medicine and western medicine treatments. After administration of Pien-Tze-Huang and cessation of previous treatments, SARS-CoV-2 tests results of the patients turned and remained negative. We believe the finding will contribute to a better understanding of atypical COVID-19 cases and hope to offer a potential therapy. Since this is a preliminary case series, larger-scale clinical trials are warranted.

References

Gao Z, Xu Y, Guo Y, Xu D, Zhang L, Wang X . A systematic review of re-detectable positive virus nucleic acid among COVID-19 patients in recovery phase. Infect Genet Evol. 2020; 85:104494. PMC: 7403029. DOI: 10.1016/j.meegid.2020.104494. View

Tian J, Yan S, Wang H, Zhang Y, Zheng Y, Wu H . Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study. Pharmacol Res. 2020; 161:105127. PMC: 7416080. DOI: 10.1016/j.phrs.2020.105127. View

Dao T, Hoang V, Gautret P . Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2020; 40(1):13-25. PMC: 7592450. DOI: 10.1007/s10096-020-04088-z. View

Zhao J, Hu H, Wan Y, Zhang Y, Zheng L, Hong Z . Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats. Exp Ther Med. 2017; 13(5):1820-1826. PMC: 5443228. DOI: 10.3892/etm.2017.4174. View

Ma J, Huo X, Chen X, Zhu W, Yao M, Qiao Y . [Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP]. Zhongguo Zhong Yao Za Zhi. 2020; 45(6):1219-1224. DOI: 10.19540/j.cnki.cjcmm.20200216.401. View

Wang J, Xing H, Qin X, Ren Q, Yang J, Li L . Pharmacological effects and mechanisms of muscone. J Ethnopharmacol. 2020; 262:113120. DOI: 10.1016/j.jep.2020.113120. View

Chang S, Kim Y, Kim Y, Kim Y, Moon S, Lee Y . Taurodeoxycholate Increases the Number of Myeloid-Derived Suppressor Cells That Ameliorate Sepsis in Mice. Front Immunol. 2018; 9:1984. PMC: 6153344. DOI: 10.3389/fimmu.2018.01984. View

Chen G, Su W, Yang J, Luo D, Xia P, Jia W . Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study. Front Med. 2020; 14(6):752-759. PMC: 7488644. DOI: 10.1007/s11684-020-0813-6. View

Toor S, Saleh R, Sasidharan Nair V, Taha R, Elkord E . T-cell responses and therapies against SARS-CoV-2 infection. Immunology. 2020; 162(1):30-43. PMC: 7730020. DOI: 10.1111/imm.13262. View

10.

Li L, Shen A, Chu J, Sferra T, Sankararaman S, Ke X . Pien Tze Huang ameliorates DSS‑induced colonic inflammation in a mouse colitis model through inhibition of the IL‑6/STAT3 pathway. Mol Med Rep. 2018; 18(1):1113-1119. DOI: 10.3892/mmr.2018.9051. View

11.

Mei Q, Li J, Du R, Yuan X, Li M, Li J . Assessment of patients who tested positive for COVID-19 after recovery. Lancet Infect Dis. 2020; 20(9):1004-1005. PMC: 7338012. DOI: 10.1016/S1473-3099(20)30433-3. View

12.

Lan L, Xu D, Ye G, Xia C, Wang S, Li Y . Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020; 323(15):1502-1503. PMC: 7047852. DOI: 10.1001/jama.2020.2783. View

13.

Xiao A, Tong Y, Gao C, Zhu L, Zhang Y, Zhang S . Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study. J Clin Virol. 2020; 127:104346. PMC: 7151472. DOI: 10.1016/j.jcv.2020.104346. View

14.

Liu H, Yang J, Yang W, Hu S, Wu Y, Zhao B . Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases. Drug Des Devel Ther. 2020; 14:551-565. PMC: 7012233. DOI: 10.2147/DDDT.S240511. View

15.

Wan Y, Shen A, Qi F, Chu J, Cai Q, Sferra T . Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p. Exp Ther Med. 2017; 14(4):3901-3907. PMC: 5639347. DOI: 10.3892/etm.2017.4972. View

16.

Phelan A, Katz R, Gostin L . The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020; 323(8):709-710. DOI: 10.1001/jama.2020.1097. View

17.

Wen C, Shyur L, Jan J, Liang P, Kuo C, Arulselvan P . Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J Tradit Complement Med. 2014; 1(1):41-50. PMC: 3942999. DOI: 10.1016/s2225-4110(16)30055-4. View

18.

Daruich A, Picard E, Boatright J, Behar-Cohen F . Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease. Mol Vis. 2019; 25:610-624. PMC: 6817734. View

19.

Zhou L, Liu K, Liu H . [Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (COVID-19) patients after discharge from hospital]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(4):281-284. DOI: 10.3760/cma.j.cn112147-20200229-00219. View

20.

Avanzato V, Matson M, Seifert S, Pryce R, Williamson B, Anzick S . Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer. Cell. 2020; 183(7):1901-1912.e9. PMC: 7640888. DOI: 10.1016/j.cell.2020.10.049. View